Oric Pharmaceuticals, Inc. (ORIC) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Oct 21, 2026.
- Filings shown
- 7
- Open-market buys
- 0
- Open-market sells
- 10
Counts cover the 7 most recent Form 4 filings Tradune holds for ORIC (filed Jul 8 – Oct 21, 2026); the score below covers only the trailing 90 days (0 buys, 7 sells). SEC EDGAR Form 4 filings for ORIC last checked Nov 21, 2026, 09:00 UTC; the latest ORIC filing Tradune holds was filed Oct 21, 2026. This is not guaranteed to be the complete record — see ORIC's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 5 filings Tradune holds for ORIC filed Aug 28 – Oct 21, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
7 open-market sales by Rule 10b5-1 checkbox
- On filings with the 10b5-1 box checked
- 7 sales· 111,700 sh
- checkbox disclosed
- On filings with the box not checked
- 0 sales· 0 sh
- not proof that no plan exists
- Not comparable
- 0 sales· 0 sh
- filed before Apr 1, 2023, or no checkbox value in the filing data
Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| Dominic PiscitelliChief Financial Officer | 0 | 5 | — | 105,000 | −$1,432,565 |
| Richard A. HeymanDirector | 0 | 2 | — | 6,700 | −$86,524 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Insider-activity score
0/ 100
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at ORIC
No open-market insider purchases (Form 4 code P) were reported for ORIC between Jul 8, 2026 and Oct 21, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 14,000 | $4.36 | 83,828 | +20% | Oct 20, 2026 |
| Open-market sale 10b5-1 box checked | 14,000 | $13.53 | 69,828 | −17% | Oct 20, 2026 |
| Option exercise Stock Option (right to buy) | 14,000 | — | — | — | Oct 20, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 3,200 | $12.91 | 203,472 (indirect) | −1.5% | Oct 1, 2026 |
| Option exercise Stock Option (right to buy) | 3,500 | — | — | — | Oct 1, 2026 |
| Open-market sale 10b5-1 box checked | 3,500 | $12.91 | 38,300 | −8.4% | Oct 1, 2026 |
| Option exercise | 3,500 | $1.60 | 41,800 | +9.1% | Oct 1, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 13,400 | $13.53 | 69,828 | −16% | Sep 28, 2026 |
| Option exercise | 13,400 | $4.36 | 83,228 | +19% | Sep 28, 2026 |
| Option exercise Stock Option (right to buy) | 13,400 | — | — | — | Sep 28, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 500 | $13.51 | 69,828 | −0.7% | Sep 24, 2026 |
| Option exercise | 600 | $4.36 | 70,428 | +0.9% | Sep 24, 2026 |
| Open-market sale 10b5-1 box checked | 100 | $13.50 | 70,328 | −0.1% | Sep 24, 2026 |
| Option exercise Stock Option (right to buy) | 600 | — | — | — | Sep 24, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 52,000 | $4.36 | 121,828 | +74% | Aug 26, 2026 |
| Option exercise Stock Option (right to buy) | 25,000 | — | — | — | Aug 26, 2026 |
| Option exercise Stock Option (right to buy) | 52,000 | — | — | — | Aug 26, 2026 |
| Open-market sale 10b5-1 box checked | 77,000 | $13.69 | 69,828 | −52% | Aug 26, 2026 |
| Option exercise | 25,000 | $6.00 | 146,828 | +21% | Aug 26, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Option exercise | 3,500 | $1.60 | 45,300 | +8.4% | Jul 24, 2026 |
| Option exercise Stock Option (right to buy) | 3,500 | — | — | — | Jul 24, 2026 |
| Open-market sale 10b5-1 box checked | 6,100 | $12.02 | 206,672 (indirect) | −2.9% | Jul 24, 2026 |
| Open-market sale 10b5-1 box checked | 7,000 | $12.02 | 38,300 | −15% | Jul 24, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 300 | $12.00 | 212,772 (indirect) | −0.1% | Jul 6, 2026 |
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to ORIC's (Oct 21, 2026).
Frequently asked about ORIC insider activity
How many insiders bought ORIC stock in these Form 4 filings?
No open-market purchases (Form 4 code P) of ORIC shares were reported by Oric Pharmaceuticals, Inc. insiders between Jul 8, 2026 and Oct 21, 2026. The 7 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.
Who filed the most recent Form 4 for ORIC?
The most recent Form 4 on this page was filed by Dominic Piscitelli (Chief Financial Officer) on Oct 21, 2026, reporting 3 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market ORIC insider sale shown?
The largest open-market sale among the filings shown was 77,000 ORIC shares at $13.69 (about $1,053,814) by Dominic Piscitelli (Chief Financial Officer) on Aug 26, 2026. Value is shares × the price reported on the Form 4; that Form 4 has the Rule 10b5-1 box checked.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for ORIC — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.